Swift, aggressive thiamin therapy may be key to preventing long-term neurological injury
A case study in how pharmacogenomic testing can be helpful if not always essential
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement